Showing results (231-240 of 2,479) with videos related to

Sort By:
Pageof 248
The Journal of Biological Chemistry|August 22, 2014
Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factorsVijayalekshmi Nair, Sandeep Sreevalsan, Riyaz Basha, et al.
Endocrinology|August 31, 2023
Flavonoids Quercetin and Kaempferol Are NR4A1 Antagonists and Suppress Endometriosis in Female MiceLei Zhang, Kumaravel Mohankumar, Gregory Martin, et al.
Urologic Oncology|April 4, 2016
CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen speciesHisashi Takeuchi, Rikiya Taoka, Chinedu O Mmeje, et al.
International Journal of Molecular Sciences|May 13, 2026
Dual Targeting of EZH2 and LSD1 Suppresses Hepatocellular Carcinoma via Disruption of Sonic Hedgehog SignalingHongDuck Yun, Ponmari Guruvaiya, Olena Levurdiak, et al.
Cytotherapy|March 17, 2010
Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatmentShannon Kidd, Lisa Caldwell, Martin Dietrich, et al.
Oncogene|August 31, 2002
Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancerAlexander Koliopanos, Jörg Kleeff, Yi Xiao, et al.
Neurobiology of Aging|November 17, 2019
Pharmacological activation of Nr4a rescues age-associated memory declineSnehajyoti Chatterjee, Emily N Walsh, Amy L Yan, et al.
Cancer Research|January 9, 2020
A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor ImmunityKeshav Karki, Gus A Wright, Kumaravel Mohankumar, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 21, 2013
Theranostic tumor homing nanocarriers for the treatment of lung cancerApurva R Patel, Mahavir B Chougule, Ed Lim, et al.
Breast Cancer Research and Treatment|July 13, 2007
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathwaysKathy Vanderlaag, Yunpeng Su, Arthur E Frankel, et al.
Pageof 248